Key result
This review discusses the creation of relevant nonhuman primate models for multiple sclerosis to enable safety and efficacy testing of biological therapies.
This review discusses the creation and utility of nonhuman primate models for multiple sclerosis to facilitate the translation of biological therapies.
NHP models may aid MS biologic testing; leaves open validation for human translation.
Biotechnology has enabled the development of specifically acting therapies for immune-mediated inflammatory disorders (IMIDs) based on biological molecules. The high species specificity precludes safety and effectivity testing in lower species (mice and rats), thus creating a need for valid experimental models in nonhuman primates (NHPs). Here, we review the creation of relevant NHP model(s) for multiple sclerosis (MS), an IMID of the human CNS. We will also discuss how the model(s) can help in the translation of a scientific principle developed in lower species into a therapy for MS.
No takes yet. Share an insight, caveat, or question.
Hart et al. (2007) conducted a review in Multiple sclerosis. Nonhuman primate models was evaluated. This review discusses the creation of relevant nonhuman primate models for multiple sclerosis to enable safety and efficacy testing of biological therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: